Retatrutide activates three hormone receptors (GLP-1, GIP, and glucagon) while tirzepatide activates two (GLP-1 and GIP)
In addition, the change of inflammatory factors often followed with oxidative stress and programmed cell death [85]
Even though these are now FDA-approved indications, insurance coverage for the Wegovy pill may vary by plan
Wegovy is indicated for people ages 12 years and older who have: A BMI of 30 kg/m 2 or higher A BMI of 27 kg/m 2 to 29.9 kg/m 2 and at least one weight-related comorbidity , such as high blood pressure, type 2 diabetes, or obstructive sleep apnea Wegovy is also indicated to reduce the risk of major cardiovascular events , such as heart attack or stroke, in people who have obesity or overweight
Premium API CagriSema With addition of cagrilintide(a long-acting amylin analog) to semaglutide, CagriSema provides better efficacy than semaglutide(Ozempic, Wegovy) and tirzepatide(Mounjaro, Zepbound) for both obesity and T2DM